Transforming Growth Factor-β3 Therapy Delays Postoperative Reossification and Improves Craniofacial Growth in...

Area of Science:

• Craniofacial surgery
• Developmental biology
• Regenerative medicine

Background:

• Postoperative reossification is a common complication after craniosynostosis surgery.
• Underexpression of transforming growth factor-β3 (TGF-β3) is implicated in craniosynostosis and reossification.
• TGF-β3 may inhibit reossification and promote better postoperative craniofacial growth.

Purpose of the Study:

• To investigate the effect of TGF-β3 administration on postoperative reossification and craniofacial growth.
• To test the hypothesis that TGF-β3 can delay reossification and improve outcomes in a rabbit model.

Main Methods:

• Hereditary coronal suture synostosis model in 30 New Zealand white rabbits.
• Suturectomy followed by treatment with bovine serum albumin (control) or TGF-β3.
• Serial 3D CT scans, cephalographs, and histomorphometric analysis at multiple time points.

Main Results:

• TGF-β3 treated sites showed significantly larger defect areas and intracranial volumes.
• Histomorphometry revealed patent suturectomy sites with significantly less new bone formation in TGF-β3 treated rabbits.
• Radiographic data indicated significant improvements in craniofacial growth in TGF-β3 treated rabbits.

Conclusions:

• TGF-β3 administration effectively delayed reossification in the rabbit model.
• TGF-β3 treatment improved craniofacial growth following suturectomy.
• Molecular therapy with TGF-β3 shows promise for clinical use in craniosynostosis treatment.